Skip to main content
. 2015 Jul 17;2:22–28. doi: 10.1016/j.plabm.2015.07.001

Table 1.

Description of sites, reagents and instruments used in the multicenter study.

Site Company Method Assay principle Sample volume (µL) Measuring range (ng/mL)
Parma, Italy BRAHMS, Hennigsdorf, Germany Kryptor BRAHMS PCT sensitive Time-Resolved Amplified Cryptate Emission (TRACE) immunoassay 50 0.02–1000
Asti, Italy Diasorin, Saluggia (VC), Italy Liaison BRAHMS PCT Two-site immunoluminometric assay 100 0.02–100
Lodi, Italy bioMérieux, Marcy l’Etoile, France Vidas BRAHMS PCT Enzyme-linked fluorescent immunoassay (ELFA) 200 0.05–200
Milano, Italy Roche Diagnostics, Mannheim, Germany Roche BRAHMS PCT Electrochemiluminescence immunoassay (ECLIA) 30 0.02–100
Alessandria, Italy Siemens Diagnostics, Marburg, Germany Siemens BRAHMS PCT One-step chemiluminescence immunoassay 100 0.02–75
Bassano del Grappa, Italy Abbott Diagnostics Abbott Park, Illinois, U.S.A Diazyme procalcitonina Latex-enhanced immunotubidimetric assay 20 0.16–56
Alessandria, Italy Siemens Healthcare Diagnostics, Marburg, Germany Diazyme procalcitonina Latex-enhanced immunotubidimetric assay 20 0.16–56
Milano, Italy Roche Diagnostics, Mannheim, Germany Diazyme procalcitonina Latex-enhanced immunotubidimetric assay 20 0.16–56
Parma, Italy Beckman Coulter Inc., Brea, CA, USA Diazyme procalcitonina Latex-enhanced immunotubidimetric assay 20 0.16–56
a

Diazyme procalcitonin, Diazyme Laboratories, Poway, CA, USA.